The exact quote is:
In this period, Admedus made significant progress getting CardioCel® into cardiothoracicwith CardioCel®.
surgery centres across Europe and the US. By the end of the current period, 23 European
centres and 20 centres in the US had used the product. These numbers have since risen
further to 27 centres in Europe and 25 centres in the US, with over 1,000 patients implanted
there is no way this mean 1000 patients to Dec 31 2014.
Ann: Admedus expands CardioCel market, page-33
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.73 |
Change
-0.180(1.01%) |
Mkt cap ! $347.9M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.73 | $38.84K | 2.167K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 668 | $17.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.90 | 91 | 3 |
View Market Depth
| Last trade - 12.32pm 16/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |